BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26828653)

  • 1. Genomic Alteration During Metastasis of Lung Adenocarcinoma.
    Tan Q; Cui J; Huang J; Ding Z; Lin H; Niu X; Li Z; Wang G; Luo Q; Lu S
    Cell Physiol Biochem; 2016; 38(2):469-86. PubMed ID: 26828653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study.
    Shi J; Hua X; Zhu B; Ravichandran S; Wang M; Nguyen C; Brodie SA; Palleschi A; Alloisio M; Pariscenti G; Jones K; Zhou W; Bouk AJ; Boland J; Hicks B; Risch A; Bennett H; Luke BT; Song L; Duan J; Liu P; Kohno T; Chen Q; Meerzaman D; Marconett C; Laird-Offringa I; Mills I; Caporaso NE; Gail MH; Pesatori AC; Consonni D; Bertazzi PA; Chanock SJ; Landi MT
    PLoS Med; 2016 Dec; 13(12):e1002162. PubMed ID: 27923066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of somatic alterations in stage I lung adenocarcinomas by next-generation sequencing.
    Zhao Y; Yang J; Chen Z; Gao Z; Zhou F; Li X; Li J; Shi S; Feng X; Sun N; Yao R; Zhou C; Chang S; Li M; Zhou Y; Li L; Zhang X; He J
    Genes Chromosomes Cancer; 2014 Apr; 53(4):289-98. PubMed ID: 24449147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.
    Garofalo A; Sholl L; Reardon B; Taylor-Weiner A; Amin-Mansour A; Miao D; Liu D; Oliver N; MacConaill L; Ducar M; Rojas-Rudilla V; Giannakis M; Ghazani A; Gray S; Janne P; Garber J; Joffe S; Lindeman N; Wagle N; Garraway LA; Van Allen EM
    Genome Med; 2016 Jul; 8(1):79. PubMed ID: 27460824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An individualized gene expression signature for prediction of lung adenocarcinoma metastases.
    Qi L; Li T; Shi G; Wang J; Li X; Zhang S; Chen L; Qin Y; Gu Y; Zhao W; Guo Z
    Mol Oncol; 2017 Nov; 11(11):1630-1645. PubMed ID: 28922552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.
    Zhang C; Zhang J; Xu FP; Wang YG; Xie Z; Su J; Dong S; Nie Q; Shao Y; Zhou Q; Yang JJ; Yang XN; Zhang XC; Li Z; Wu YL; Zhong WZ
    J Thorac Oncol; 2019 Nov; 14(11):1912-1923. PubMed ID: 31446140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic profiling of multiple sequentially acquired tumor metastatic sites from an "exceptional responder" lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment response.
    Biswas R; Gao S; Cultraro CM; Maity TK; Venugopalan A; Abdullaev Z; Shaytan AK; Carter CA; Thomas A; Rajan A; Song Y; Pitts S; Chen K; Bass S; Boland J; Hanada KI; Chen J; Meltzer PS; Panchenko AR; Yang JC; Pack S; Giaccone G; Schrump DS; Khan J; Guha U
    Cold Spring Harb Mol Case Stud; 2016 Nov; 2(6):a001263. PubMed ID: 27900369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic heterogeneity of actionable genes between primary and metastatic tumor in lung adenocarcinoma.
    Kim EY; Cho EN; Park HS; Kim A; Hong JY; Lim S; Youn JP; Hwang SY; Chang YS
    BMC Cancer; 2016 Jan; 16():27. PubMed ID: 26782967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples.
    Hintzsche J; Kim J; Yadav V; Amato C; Robinson SE; Seelenfreund E; Shellman Y; Wisell J; Applegate A; McCarter M; Box N; Tentler J; De S; Robinson WA; Tan AC
    J Am Med Inform Assoc; 2016 Jul; 23(4):721-30. PubMed ID: 27026619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a human lung cancer cell line with high metastatic potential to multiple organs: gene expression associated with metastatic potential in human lung cancer.
    Nakano T; Shimizu K; Kawashima O; Kamiyoshihara M; Kakegawa S; Sugano M; Ibe T; Nagashima T; Kaira K; Sunaga N; Ohtaki Y; Atsumi J; Takeyoshi I
    Oncol Rep; 2012 Nov; 28(5):1727-35. PubMed ID: 22922681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced expression of long non-coding RNA ZXF1 promoted the invasion and metastasis in lung adenocarcinoma.
    Zhang L; Zhou XF; Pan GF; Zhao JP
    Biomed Pharmacother; 2014 May; 68(4):401-7. PubMed ID: 24721325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genomic dynamics during progression of lung adenocarcinomas.
    Yang B; Luo L; Luo W; Zhou Y; Yang C; Xiong T; Li X; Meng X; Li L; Zhang X; Wang Z; Wang Z
    J Hum Genet; 2017 Aug; 62(8):783-788. PubMed ID: 28381877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting survival within the lung cancer histopathological hierarchy using a multi-scale genomic model of development.
    Liu H; Kho AT; Kohane IS; Sun Y
    PLoS Med; 2006 Jul; 3(7):e232. PubMed ID: 16800721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligogenic germline mutations identified in early non-smokers lung adenocarcinoma patients.
    Renieri A; Mencarelli MA; Cetta F; Baldassarri M; Mari F; Furini S; Piu P; Ariani F; Dragani TA; Frullanti E
    Lung Cancer; 2014 Aug; 85(2):168-74. PubMed ID: 24954872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational Landscape and Evolutionary Pattern of Liver and Brain Metastasis in Lung Adenocarcinoma.
    Jiang T; Fang Z; Tang S; Cheng R; Li Y; Ren S; Su C; Min W; Guo X; Zhu W; Zhang H; Hou L; Pan Y; Zhou Z; Zhang J; Zhang G; Yue Z; Chen L; Zhou C
    J Thorac Oncol; 2021 Feb; 16(2):237-249. PubMed ID: 33188911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex genomic test of mutation and fusion genes in small biopsy specimen of lung cancer.
    Oshita F; Kasajima R; Miyagi Y
    J Exp Ther Oncol; 2016 Jul; 11(3):189-194. PubMed ID: 28471124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker woman.
    Bonanno L; Calabrese F; Nardo G; Calistri D; Tebaldi M; Tedaldi G; Polo V; Vuljan S; Favaretto A; Conte P; Amadori A; Rea F; Indraccolo S
    Lung Cancer; 2016 Jun; 96():52-5. PubMed ID: 27133750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma.
    Chen YC; Lin MC; Hsiao CC; Zheng YX; Chen KD; Sung MT; Chen CJ; Wang TY; Lin YY; Chang HC; Chen YM; Chang JC
    Oncotarget; 2017 Jul; 8(28):45710-45724. PubMed ID: 28498804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide DNA Methylation Analysis Reveals
    Niu X; Liu F; Zhou Y; Zhou Z; Zhou D; Wang T; Li Z; Ye X; Yu Y; Weng X; Zhang H; Ye J; Liao M; Liu Y; Chen Z; Lu S
    Clin Cancer Res; 2017 Sep; 23(17):5003-5014. PubMed ID: 28490462
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduced transcription of the RB2/p130 gene in human lung cancer.
    Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
    Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.